About Us
Montauk is a technology development and acquisition company focused on new business formation, centered on sustainability, built on defensible technology, and intellectual property with a rapid development model, collaborative culture, and market-driven.
Montauk Alpha, a business accelerator organized and managed by Montauk Technologies, is designed to attract new technologies, entrepreneurs, start-up companies, corporate partners, consulting firms, academic and research institutions, governmental agencies, NGOs, foundations, and impact investors - creating the Montauk Alpha Ecosystem pursuing critically important sustainability initiatives aligned with our Imperatives and Targeted Technologies. The objective is to accelerate the development of new business opportunities in response to large addressable market opportunities. While we seek to generate superior investment returns in each opportunity, we are equally focused on achieving broader stakeholder benefits.
Montauk Alpha will offer participating companies and entrepreneurs directly or through its Ecosystem partners, consultants, and advisors the following services:
- Sustainable themes linked to actionable technologies
- Ideation with entrepreneurs
- Business plan review
- Market assessment
- Intellectual property review
- Financial model review
- Capitalization plans and financing
- New company formation and launch
- Distribution channels
- Strategic partnering
- M&A
- Governance
- CEO coaching
- Ongoing strategic advice
Montauk Alpha intends to organize and host periodic innovation conferences around its targeted themes at its location at AltaSea.
AltaSea / Montauk
Montauk as anchor tenant at the “La Kretz Blue Economy Incubator” at AltaSea at the Port of Los Angeles.
Leadership
Joe Boystak, Chairman
Will Boystak, Business Development and Corporate Finance Analyst
Joe Boystak, Chairman
Experienced venture capitalist - Founding Managing Partner, Health2047 Capital Partners; senior investment banker - Founding Managing Director, Global Life Sciences, Jefferies; CEO, Brightwaters Capital - new business formation and serial company co-founder in bio-medical, tech, IT, and AI spin-outs from UCLA, Johns Hopkins, Harvard/MGH,
Experienced venture capitalist - Founding Managing Partner, Health2047 Capital Partners; senior investment banker - Founding Managing Director, Global Life Sciences, Jefferies; CEO, Brightwaters Capital - new business formation and serial company co-founder in bio-medical, tech, IT, and AI spin-outs from UCLA, Johns Hopkins, Harvard/MGH, Memorial Sloan Kettering, Caltech / JPL, among others. Named co-inventor on 5 issued US/EU patents for first-in-class medical technology.
Boston University, BA, Johns Hopkins, MHS, Wharton School, Executive Education
https://www.linkedin.com/in/joseph-a-boystak-000b472b/
Dean Wiberg, CEO
Will Boystak, Business Development and Corporate Finance Analyst
Joe Boystak, Chairman
Prior experience includes 35+ years of technology development, system and senior project management, business development and business formation - Jet Propulsion Lab, IBM, Westinghouse, and Northrop Grumman.
Weber State, BS, Brigham Young, MS, University of Utah, MBA
https://www.linkedin.com/in/dean-wiberg-7015a4b/
Will Boystak, Business Development and Corporate Finance Analyst
Will Boystak, Business Development and Corporate Finance Analyst
Will Boystak, Business Development and Corporate Finance Analyst
Investment Banking Analyst - Stifel; Internships - Omelet LLC and Institute for Creative Technologies at the University of Southern California. Senior Sailing Instructor, California Yacht Club, Volunteer, Heal the Bay & Surfrider Foundation.
University of California, Santa Barbara,
BA (Honors), Phi Beta Kappa
https://www.linkedin.com/in/william-b-205791a0/
Scientific and technical advisory Board (Stab)
Coming Soon